JP2014513678A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014513678A5 JP2014513678A5 JP2014504051A JP2014504051A JP2014513678A5 JP 2014513678 A5 JP2014513678 A5 JP 2014513678A5 JP 2014504051 A JP2014504051 A JP 2014504051A JP 2014504051 A JP2014504051 A JP 2014504051A JP 2014513678 A5 JP2014513678 A5 JP 2014513678A5
- Authority
- JP
- Japan
- Prior art keywords
- veneered
- humanized
- chimeric
- human antibody
- isolated human
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161473107P | 2011-04-07 | 2011-04-07 | |
| US61/473,107 | 2011-04-07 | ||
| PCT/US2012/032635 WO2012139069A2 (en) | 2011-04-07 | 2012-04-06 | Compositions and methods for treating diseases of protein aggregation involving ic3b deposition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014513678A JP2014513678A (ja) | 2014-06-05 |
| JP2014513678A5 true JP2014513678A5 (https=) | 2015-06-11 |
Family
ID=46966276
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014504051A Pending JP2014513678A (ja) | 2011-04-07 | 2012-04-06 | Ｉｃ３ｂ沈着を伴うタンパク質凝集に関する疾患を治療するための組成物及び方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US20140186371A1 (https=) |
| EP (1) | EP2694109A4 (https=) |
| JP (1) | JP2014513678A (https=) |
| CA (1) | CA2832106A1 (https=) |
| WO (1) | WO2012139069A2 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12384848B2 (en) | 2011-12-19 | 2025-08-12 | The Rockefeller University | Anti-inflammatory polypeptides |
| EP2793943B1 (en) | 2011-12-19 | 2018-09-26 | The Rockefeller University | Non-sialylated anti-inflammatory polypeptides |
| US10035848B2 (en) * | 2014-01-08 | 2018-07-31 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Antibody targeting cell surface deposited complement protein C3d and use thereof |
| EP3191509B1 (en) * | 2014-09-09 | 2019-02-20 | Euro-diagnostica AB | Antibodies specific for complement component c4d and uses thereof |
| AU2016226115B2 (en) | 2015-03-04 | 2021-03-25 | The Rockefeller University | Anti-inflammatory polypeptides |
| WO2019089653A1 (en) * | 2017-10-30 | 2019-05-09 | Apellis Pharmaceuticals, Inc. | Treatment of disorders |
| CN112512566A (zh) | 2018-04-03 | 2021-03-16 | 赛诺菲 | 抗原性爱泼斯坦-巴尔病毒多肽 |
| BR112020019938A2 (pt) | 2018-04-03 | 2021-01-26 | Sanofi | polipeptídeos antigênicos de vírus sincicial respiratório |
| CN112512564A (zh) | 2018-04-03 | 2021-03-16 | 赛诺菲 | 铁蛋白蛋白 |
| CA3095174A1 (en) | 2018-04-03 | 2019-10-10 | Sanofi | Antigenic ospa polypeptides |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU9374198A (en) * | 1997-09-08 | 1999-03-29 | Idec Pharmaceuticals Corporation | Methods for producing human antibodies in scid mice using dendritic cells |
| US8007798B2 (en) * | 1997-11-21 | 2011-08-30 | Genentech, Inc. | Treatment of complement-associated disorders |
| US20030235594A1 (en) * | 1999-09-14 | 2003-12-25 | Antigen Express, Inc. | Ii-Key/antigenic epitope hybrid peptide vaccines |
| AU2001287000A1 (en) * | 2000-09-01 | 2002-03-13 | The Center For Blood Research, Inc. | Modified polypeptides stabilized in a desired conformation and methods for producing same |
| US6820011B2 (en) * | 2001-04-11 | 2004-11-16 | The Regents Of The University Of Colorado | Three-dimensional structure of complement receptor type 2 and uses thereof |
| US20090004183A1 (en) * | 2004-07-23 | 2009-01-01 | Taylor Ronald P | Compositions and Methods for Regulating the Alternative Pathway of Complement |
| WO2006083533A2 (en) * | 2005-01-14 | 2006-08-10 | The Regents Of The University Of California | Compositions and methods for inhibiting drusen formation and for diagnosing or treating drusen-related disorders |
| BRPI0618338A2 (pt) * | 2005-11-07 | 2011-08-23 | Scripps Resarch Inst | uso de inibidor de sinalização de fator tecidual, método para identificar um agente que inibe a sinalização de tf/viia, composições farmacêuticas e kit |
| UY31520A1 (es) * | 2007-12-11 | 2009-08-03 | Proteinas de union a antigenos | |
| US9291622B2 (en) * | 2009-05-21 | 2016-03-22 | Apellis Pharmaceuticals, Inc. | Complement assays and uses thereof |
-
2012
- 2012-04-06 EP EP12768510.5A patent/EP2694109A4/en not_active Withdrawn
- 2012-04-06 WO PCT/US2012/032635 patent/WO2012139069A2/en not_active Ceased
- 2012-04-06 JP JP2014504051A patent/JP2014513678A/ja active Pending
- 2012-04-06 CA CA2832106A patent/CA2832106A1/en not_active Abandoned
- 2012-04-06 US US14/110,137 patent/US20140186371A1/en not_active Abandoned
- 2012-04-06 US US13/441,818 patent/US20120258041A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014513678A5 (https=) | ||
| SI2847225T1 (sl) | Protitelesa proti klavdinu 18.2, koristna v diagnozi raka | |
| JP2016502162A5 (https=) | ||
| IL235607A0 (en) | Combination therapy involving antibodies against claudin 18.2 for treatment of cancer | |
| LT3378535T (lt) | Humanizuoti antikūnai, atpažįstantys alfa-sinukleiną | |
| IL240335A0 (en) | Treatment of cancer using humanized anti-egfrviii chimeric antigen receptor | |
| DK3191517T3 (da) | Krydsreaktive siglec-antistoffer | |
| EP2935321A4 (en) | CHIMERIC ANTIGEN RECEPTORS | |
| SI2935329T1 (sl) | Protitelesa, ki se vežejo na humani programirani smrtni ligand 1 (PD-L1) | |
| DK2917360T3 (da) | Antistoffer mod S. aureus-overflade-determinanter | |
| LT3701971T (lt) | Junginiai, naudingi hibridinio imunoglobulino, turinčio nepeptidilo ryšį, gamyboje | |
| EP2882295A4 (en) | ANTIMICROBIAL SOLID SURFACES AND TREATMENTS AND METHOD FOR THE PRODUCTION THEREOF | |
| JP2014518898A5 (https=) | ||
| JP2011170856A5 (https=) | ||
| JP2013194055A5 (https=) | ||
| HRP20180928T1 (hr) | Protutijela za ligande bradikinin b1 receptora | |
| JP2015501646A5 (https=) | ||
| BR112014025299A8 (pt) | anticorpo de reação cruzada dirigido contra staphylococcus aureus, preparação farmacêutica e diagnóstica compreendendo o anticorpo, métodos de anticorpo de reação cruzada contra staphylococcus aureus | |
| IL244936A0 (en) | Cross-reactive staphylococcus aureus antibody sequences | |
| IL239370A0 (en) | A specific antibody does not. coli with multidrug resistance | |
| DK3154583T3 (da) | Humane monoklonale antistoffer mod gangliosid gd2 | |
| EP2695897A4 (en) | NEW ANTI-RECEPTOR ANTIBODY OF IL-23 HUMAN | |
| HUE049860T2 (hu) | IL-ß-t neutralizáló, humán monoklonális antitestek | |
| JP2012209621A5 (https=) | ||
| CL2013000607A1 (es) | Anticuerpo o porción del mismo enlazante al antígeno caracterizado porque se une especificamente a vegfr-3. |